T. Rowe Price Investment Management

T. Rowe Price Investment Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

T. Rowe Price Investment Management’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,352,252	Closed	-$28.3M	–	662
2023 Q4	$28.3M	Buy	4,352,252 +253,385	+6%	+$1.63M	0.02%	456
2023 Q3	$38.7M	Buy	4,098,867 +183,000	+5%	+$2.2M	0.03%	401
2023 Q2	$54.7M	Buy	3,915,867 +177,981	+5%	+$3.03M	0.04%	366
2023 Q1	$70.1M	Buy	3,737,886 +130,233	+4%	+$2.14M	0.05%	317
2022 Q4	$49.7M	Buy	3,607,653 +1,965,560	+120%	+$30.1M	0.04%	355
2022 Q3	$31.4M	Buy	+1,642,093	New	+$29.9M	0.03%	399

Other funds holding CDMO

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Royal Bank of Canada

Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return